financetom
Business
financetom
/
Business
/
IT firm Super Micro's Q1 revenue misses estimates on delayed design wins
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
IT firm Super Micro's Q1 revenue misses estimates on delayed design wins
Oct 23, 2025 6:57 AM

Overview

* Super Micro fiscal Q1 2026 revenue misses analyst expectations due to shifted design wins

* Company sees robust demand for AI solutions, reiterates FY 2026 revenue of at least $33B

* Super Micro received over $12B in new design wins for delivery in fiscal Q2 2026

Outlook

* Super Micro expects FY 2026 revenue of at least $33 bln

* Company sees Q1'26 revenue at $5 bln, below prior $6 bln-$7 bln guidance

* Recent design wins exceed $12 bln, deliveries expected in Q2'26

Result Drivers

* DESIGN WIN SHIFT - Revenue impacted as design win upgrades pushed expected Q1 revenue to Q2

* STRONG AI DEMAND - Robust demand for AI liquid-cooled solutions and multi-quarter volume deployments

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q1 Sales Miss $5 bln $6.51

bln (16

Analysts

)

Analyst Coverage

* The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 7 "strong buy" or "buy", 10 "hold" and 3 "sell" or "strong sell"

* The average consensus recommendation for the computer hardware peer group is "buy."

* Wall Street's median 12-month price target for Super Micro Computer Inc ( SMCI ) is $48.00, about 14.2% below its October 21 closing price of $54.82

* The stock recently traded at 20 times the next 12-month earnings vs. a P/E of 18 three months ago

Press Release:

For questions concerning the data in this report, contact [email protected]. For any other questions or feedback, contact .

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Atlassian Insider Sold Shares Worth $1,247,202, According to a Recent SEC Filing
Atlassian Insider Sold Shares Worth $1,247,202, According to a Recent SEC Filing
Aug 24, 2024
04:47 PM EDT, 08/22/2024 (MT Newswires) -- Michael Cannon-Brookes, 10% Owner, Director, Co-CEO, Co-Founder, on August 21, 2024, sold 7,948 shares in Atlassian ( TEAM ) for $1,247,202. Following the Form 4 filing with the SEC, Cannon-Brookes has control over a total of 214,596 shares of the company, with 214,596 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1650372/000156218024006465/xslF345X05/primarydocument.xml Price: 155.00, Change: -0.87, Percent...
Intuit Beats Fiscal Fourth-Quarter Views on Gains From QuickBooks, Credit Karma
Intuit Beats Fiscal Fourth-Quarter Views on Gains From QuickBooks, Credit Karma
Aug 24, 2024
04:58 PM EDT, 08/22/2024 (MT Newswires) -- Intuit (INTU) late Thursday reported stronger-than-expected fiscal fourth-quarter results, driven by revenue gains in the financial technology platform's QuickBooks and Credit Karma offerings. Adjusted per-share earnings jumped to $1.99 during the three months ended July 31 from $1.65 a year earlier, topping the consensus compiled by Capital IQ of $1.85. Revenue increased 17%...
Jazz Pharmaceuticals Epilepsies Drug Study Misses Primary Efficacy Goal
Jazz Pharmaceuticals Epilepsies Drug Study Misses Primary Efficacy Goal
Aug 24, 2024
04:48 PM EDT, 08/22/2024 (MT Newswires) -- Jazz Pharmaceuticals ( JAZZ ) said Thursday a phase 3 trial in Japan of a cannabidiol oral solution for treatment-resistant epilepsies didn't meet the primary efficacy objective. The trial did not meet the primary efficacy endpoint of a pre-specified percentage change in indication-associated seizure frequency during the treatment period (up to 16 weeks)...
Onex Fund to Acquire a Majority Stake in German Manufacturer Fischbach KG
Onex Fund to Acquire a Majority Stake in German Manufacturer Fischbach KG
Aug 24, 2024
04:51 PM EDT, 08/22/2024 (MT Newswires) -- Onex ( ONEXF ) on Thursday said its Onex Partners Opportunities Fund is taking a majority stake in German manufacturer Fischbach KG for an undisclosed price. The private equity company said Fischbach is the world's largest provider of cartridge packaging solutions for sealants and adhesives used in building repair, renovation, & construction, aftermarket...
Copyright 2023-2026 - www.financetom.com All Rights Reserved